主要文件

查看所有文档

327484

铂

Name: 铂
Brand: ALDRICH

shot, ≤3 mm, ≥99.9% trace metals basis

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

化学文摘社编号:

7440-06-4

分子量:

195.08

NACRES:

NA.23

PubChem Substance ID:

24859665

UNSPSC Code:

12141734

EC Number:

231-116-1

MDL number:

MFCD00011179

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

assay

≥99.9% trace metals basis

form

shot

composition

reaction suitability

core: platinum

resistivity

10.6 μΩ-cm, 20°C

particle size

≤3 mm

bp

3827 °C (lit.)

mp

1772 °C (lit.)

density

21.45 g/cm³ (lit.)

SMILES string

[Pt]

InChI

1S/Pt

InChI key

BASFCYQUMIYNBI-UHFFFAOYSA-N

说明

Application

Platinum shot may be used in the preparation of (La_xCe_1-x)_1.33Pt₄Ga₁₀(0≤ x ≤1) single crystals, a potential non Fermi-liquid (NFL).

存储类别

13 - Non Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Synthesis, structure, and magnetic behavior of (LaxCe 1- x) 1.33 Pt 4 Ga 10 (0? x? 1).

Macaluso, et al.

J. Alloy Compounds, 600, 193-198 (2014)

In vivo monitoring the process of tumor growth, metastasis and bacterial infection expressing GFP via real-time optical imaging.

Tao Xiong et al.

Journal of biomedical nanotechnology, 9(2), 274-280 (2013-05-01)

Noninvasive molecular fluorescence imaging in vivo which combines Optical imaging with genetic marker technology can real time monitor the development of tumor, through the use of human adenoid cystic carcinoma cell (ACC-M) and lung carcinoma cells SPC-A1 were thansfected by

Interstitial lung disease associated with gefitinib in Japanese patients with EGFR-mutated non-small-cell lung cancer: combined analysis of two Phase III trials (NEJ 002 and WJTOG 3405).

Hiroaki Akamatsu et al.

Japanese journal of clinical oncology, 43(6), 664-668 (2013-04-16)

Interstitial lung disease associated with gefitinib is a critical adverse reaction. When geftinib was administered to EGFR-unknown patients, the interstitial lung disease incidence rate was approximately 3-4% in Japan, and usually occurs during the first 4 weeks of treatment. However

查看所有相关文献

全球贸易项目编号

货号	GTIN
327484-1G	04061826662328